Scorpius Holdings Announces Collaboration with KaloCyte to Advance Manufacturing for ErythroMer(TM)
(NYSE MKT:SCPX), DURHAM, N.C., Jan. 22, 2025 (GLOBE NEWSWIRE) — Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract development and manufacturing organization (“CDMO”), today announced its collaboration with KaloCyte, a pioneering pre-clinical company in the field of therapeutic innovation. Under this initial project, Scorpius will utilize its scientific and technical […]